367 results on '"Creutzberg, Carien L"'
Search Results
2. Sexual health—a topic for cancer patients receiving oncological treatment with palliative intent
3. Effect of reduced follow-up care on patient satisfaction with care among patients with endometrial cancer: The ENSURE randomized controlled trial
4. Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup
5. MR-based follow-up after brachytherapy and proton beam therapy in uveal melanoma
6. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials
7. Predictive Factors for Toxicity After Primary Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review
8. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation
9. Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II
10. Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
11. p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial
12. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts
13. Automated causal inference in application to randomized controlled clinical trials
14. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients
15. Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy
16. Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
17. Psychometric validation of the European Organisation for Research and Treatment of Cancer–Quality of Life Questionnaire Sexual Health (EORTC QLQ-SH22)
18. Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making
19. Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial
20. NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update
21. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes
22. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma
23. Management of conjunctival melanoma with local excision and adjuvant brachytherapy
24. PARP and PD-1/PD-L1 checkpoint inhibition in recurrent or metastatic endometrial cancer
25. A sexual rehabilitation intervention for women with gynaecological cancer receiving radiotherapy (SPARC study): design of a multicentre randomized controlled trial
26. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
27. Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative
28. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high-and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia
29. 3408: Ten-year results of the PORTEC-3 trial: adjuvant therapy for women with high-risk endometrial cancer
30. 1857: Ruthenium-106 brachytherapy for uveal melanoma: impact of dose deviations
31. 1681: Intuitively customizable AI-based cervix brachytherapy treatment planning
32. 919: Randomised trial of nurse-led sexual rehabilitation after radiotherapy for gynaecological cancers
33. Time Trends in the Treatment and Survival of 5036 Uveal Melanoma Patients in The Netherlands over a 30-Year Period.
34. Ruthenium-106 brachytherapy for choroidal melanoma without transpupillary thermotherapy: Similar efficacy with improved visual outcome
35. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia
36. Radiation therapy combined with hyperthermia versus cisplatin for locally advanced cervical cancer: Results of the randomized RADCHOC trial
37. Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
38. Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer
39. Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma
40. Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial
41. Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios
42. Cancer of the corpus uteri
43. Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk Factors
44. Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer.
45. International validation of two EORTC questionnaires for assessment of health‐related quality of life for patients with high‐grade non‐Hodgkin lymphoma (QLQ‐NHL‐HG29) and low‐grade non‐Hodgkin lymphoma (QLQ‐NHL‐LG20)
46. An easy, fast, and accurate way for implementing the standards of care for the management of patients with endometrial carcinoma into daily clinical practice: the ESGO mobile app.
47. European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023.
48. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
49. Qualitative Accounts of Patients' Determinants of Vaginal Dilator Use after Pelvic Radiotherapy
50. Nomograms for Prediction of Outcome With or Without Adjuvant Radiation Therapy for Patients With Endometrial Cancer: A Pooled Analysis of PORTEC-1 and PORTEC-2 Trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.